Belatacept and the Risk of Cytomegalovirus, BK Polyomavirus, and Epstein–Barr Virus Post‐transplant Lymphoproliferative Disease After Kidney Transplantation: A Meta‐Analysis and Systematic Review
Background The long‐term risk of cytomegalovirus (CMV), Epstein–Barr virus (EBV)‐associated post‐transplant lymphoproliferative disorder (PTLD), and BK viral infections from belatacept is unclear. This review aimed to evaluate these outcomes. Methods Several databases were reviewed from inception through September 2025...